| Document Date: 2009-08-27 15:08:44
Open Document File Size: 81,50 KBShare Result on Facebook
Company PET / Gynecologic Cancer Intergroup / / Facility Stable Disease / / IndustryTerm imaging / / MedicalCondition non-target disease / breast disease / tumor / ovarian cancer / specific hematologic malignancies / measurable disease / cancer / diseases / tumors / disease / stable disease / lymphangitis / Disease Parameters Measurable disease / cysts / prostate cancer / solid tumor / pericardial effusions / solid tumors / metastases / progressive disease / Non-measurable disease / objective disease / germ cell tumors / inflammatory / fibrosis / / Position investigator / physician / representative / / ProvinceOrState Connecticut / / Technology radiation / Ultrasound / x-ray / MRI / /
SocialTag |
11. MEASUREMENT OF EFFECT Please provide response criteria. If the criteria for solid tumors below are not applicable, the investigator(s) should provide disease-appropriate criteria (e.g., for specific hematologic mal